General Atlantic: Investment Portfolio & Startup News

General Atlantic

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Verdiva Bio secures £333.5m Series A led by Forbion and General Atlantic to develop next-gen weight loss therapies

9 Jan 2025

Verdiva Bio secures £333.5m Series A led by Forbion and General Atlantic to develop next-gen weight loss therapies

Verdiva Bio develops next-generation obesity and metabolic disease therapies, advancing oral and injectable treatment candidates to improve access, adherence and long-term outcomes.

General Atlantic

- Life Sciences
generalatlantic.com
Update Information

More venture news

LO:TECH
2 Nov 2026
LO:TECH secures a £9m Series A round led by MMC to build a 24/7 trading firm for traditional, digital and onchain markets
Series AFintech
Circuit Mind
28 Oct 2026
Circuit Mind raises £19m including a Series A round led by Norwest to design and check circuit boards automatically
Series AIndustrial
adsilico
26 Oct 2026
adsilico unlocks a £10m Series A round led by PXN Ventures for virtual testing of implantable medical devices
Series ALife Sciences

General Atlantic: Investment Portfolio & Startup News

Investment Portfolio

Verdiva Bio secures £333.5m Series A led by Forbion and General Atlantic to develop next-gen weight loss therapies

More venture news

LO:TECH secures a £9m Series A round led by MMC to build a 24/7 trading firm for traditional, digital and onchain markets

Circuit Mind raises £19m including a Series A round led by Norwest to design and check circuit boards automatically

adsilico unlocks a £10m Series A round led by PXN Ventures for virtual testing of implantable medical devices